Suppr超能文献

制备大孔冷冻凝胶作为生物人工肝支持的潜在肝细胞载体。

Fabrication of macroporous cryogels as potential hepatocyte carriers for bioartificial liver support.

作者信息

Jain Era, Damania Apeksha, Shakya Akhilesh Kumar, Kumar Anupam, Sarin Shiv K, Kumar Ashok

机构信息

Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India.

Institute of Liver and Biliary Sciences, New Delhi, India.

出版信息

Colloids Surf B Biointerfaces. 2015 Dec 1;136:761-71. doi: 10.1016/j.colsurfb.2015.10.012. Epub 2015 Oct 23.

Abstract

Two different cryogels composed of copolymer of acrylonitrile (AN) and N-vinyl-2-pyrrolidone (NVP) (poly(AN-co-NVP)) and interpenetrated polymer networks (IPN) of chitosan and poly(N-isopropylacrylamide) (poly(NiPAAm)-chitosan) were fabricated by gelation at sub-zero temperatures. The two cryogels possess an interconnected network of macropores of size 20-100 μm and efficient transport properties as determined by physiochemical analysis. Both cryogels support in vitro growth and function of fibroblasts (COS-7) and human liver hepatocarcinoma cells (HepG2). The cryogels are hemocompatible as demonstrated by low albumin adsorption and platelet adherence. Furthermore, in vivo implantation of poly(NiPAAm)-chitosan cryogel in mice shows its biocompatibility with the surrounding tissue. Primary rat hepatocytes grown on poly(NiPAAm)-chitosan cryogel for 96 h formed cellular aggregates and maintained their functions in terms of, ammonia removal, ureagenesis and drug detoxification. Cryogel-based closed continuous bioreactor systems could maintain HepG2 cells at high density for 7 days. Off-line clinical evaluation of these cryogel-based bioreactors showed the ability of immobilized cells to detoxify circulating plasma obtained from patients with acute on chronic liver failure (ACLF). Altogether, the presented data suggests cryogels as a potential bioreactor matrix for bio-artificial liver support system.

摘要

通过在零下温度下凝胶化制备了两种不同的冷冻凝胶,一种由丙烯腈(AN)和N-乙烯基-2-吡咯烷酮(NVP)的共聚物(聚(AN-co-NVP))组成,另一种是壳聚糖与聚(N-异丙基丙烯酰胺)(聚(NiPAAm)-壳聚糖)的互穿聚合物网络(IPN)。通过物理化学分析确定,这两种冷冻凝胶具有相互连接的20-100μm大孔网络和高效的传输特性。两种冷冻凝胶都支持成纤维细胞(COS-7)和人肝癌细胞(HepG2)的体外生长和功能。低白蛋白吸附和血小板黏附表明冷冻凝胶具有血液相容性。此外,聚(NiPAAm)-壳聚糖冷冻凝胶在小鼠体内的植入显示了其与周围组织的生物相容性。在聚(NiPAAm)-壳聚糖冷冻凝胶上生长96小时的原代大鼠肝细胞形成细胞聚集体,并在氨清除、尿素生成和药物解毒方面保持其功能。基于冷冻凝胶的封闭式连续生物反应器系统可以将HepG2细胞高密度维持7天。对这些基于冷冻凝胶的生物反应器的离线临床评估表明,固定化细胞能够对从慢性肝功能衰竭急性发作(ACLF)患者获得的循环血浆进行解毒。总之,所呈现的数据表明冷冻凝胶作为生物人工肝支持系统的潜在生物反应器基质。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验